A 63-year-old man notes that his exercise tolerance has diminished over the past year and that he is limited to climbing 1 flight of stairs, reduced from 2 flights previously. His physical examination reveals a late peaking systolic ejection murmur, and his carotid upstrokes are delayed.
There are also truly asymptomatic patients with severe AS who are at increased risk who also may benefit from AVR (i.e., those with very severe AS, those with abnormal stress test results, and probably those with high and increasing levels of biomarkers, especially natriuretic peptides) (3) (4) (5) (6) (7) . In these asymptomatic patients, certainty regarding severity is even more critical because the benefit is less definite than if symptoms were present. Obviously, the clinical problem posed is in defining the word "severe." In some cases, the diagnosis is apparent but in others, such as in the aforementioned case, the decision is more difficult because severe is as much a concept as it is a number or group of numbers. Severe AS is that level of left ventricular (LV) outflow obstruction that causes more than mild hypertrophy, abnormal coronary blood flow, and diastolic and systolic LV dysfunction that act in concert to cause symptoms, LV damage, and cardiac death. Could we be so naive as to believe that all patients who, despite 
